# A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

> **NCT01401985** · PHASE2 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 95 (actual)

## Conditions studied

- Opioid Induced Constipation

## Interventions

- **DRUG:** TD-1211
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01401985
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-05
- **Final completion:** 2012-08
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401985, "A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01401985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*